Part I: 8:30 am – Noon | Part II: 1:30 pm – 4:30 pm | Audience Q&A: 4:30 pm – 5:30 pm
Program Chairs: Raymond T. Chung, MD, FAASLD; Kimberly A. Brown, MD, FAASLD; Lawrence Friedman, MD, FAASLD
Continuing Education Credits: Up to 7.00 CME Credits Offered | Up to 7.00 ABIM MOC Points Offered | Up to 7.00 Contact Hours Offered
Program Agenda
Part I (On Demand)
Scheduled in live program for 8:30 am – 12:00 pm
Welcome and Introductions (5 min)
Session I: The Changing Practice of Hepatology
- The Evolution of Personalized Medicine in Hepatology Practice; Scott L. Friedman
- Toward a Biopsy Free World; Elliot Tapper
- Care of Patients with Advanced Liver Disease: A Team Sport (include frailty, Pall Care, Psychiatry); Victor Navarro
- Measuring the Unmeasurable: Incorporating Quality Metrics into the Care of Patients with Cirrhosis; Michael Volk
- Virtual Care: The Future is Now (focus on COVID-19); Sanjeev Arora
Session II: New Concepts in Metabolic and Toxic Liver Disease
- NAFLD Beyond Obesity (Incorporate lean NAFLD and Pediatric, Maternal/Fetal relationship); Kathleen Corey
- Rethinking Management of Alcohol-associated Liver Disease: The Other Fatty Liver Epidemic (include post-bariatric risk for AUD); Mack Mitchell
- The Gut-Liver Axis: What the Clinician Needs to Know; Anna Mae Diehl
Session III: The Immune System and the Liver
- Evolving Management of Autoimmune Liver Disease: Beyond Conventional Immunosuppression; Marlyn Mayo
- Liver Disease Related to Cancer Immunotherapy; Michael Dougan
- DILI as an Immune Disorder of the Liver: Implications for Management; Paul Watkins
Part II (On Demand)
Scheduled in live program for 1:30 pm – 4:30 pm
Session IV: Rethinking Complications of Liver Disease
- Acute-on-Chronic Liver Failure: Evolving Concepts; Jacqueline O’Leary
- Portal Hypertension: Revisiting our Principles; Guadalupe Garcia-Tsao
- Hemostasis and Thrombosis in Chronic Liver Disease: New Concepts in Management (PVT, management of progressive liver disease, management of procedures); Stephen Caldwell
- Evolving Strategies to Optimize Outcome in Liver Transplantation; Julie Heimbach
- Transformation of the HCC Management Paradigm; Jorge Marrero
Session V: Revising Our Goals in Viral Hepatitis
- Hepatitis C: Cure, Yes, but We’re Not Done Yet; David Thomas
- HBV and HDV: Can We Now Talk About Cure?; Anna S. Lok
- Other Viruses Affecting the Liver, including SARS-CoV-2; Jordan Feld
Audience Q&A (Live)
Scheduled in live program for Saturday, November 14 from 4:30 pm – 5:30 pm